INMB

Analyst Sentiment

Wall St. Consensus
Buy
9 analysts·Limited coverage
64
Score
6 Buy (67%)2 Hold (22%)1 Sell (11%)
Rating Breakdown
Strong Buy
00%
Buy
667%
Hold
222%
Sell
111%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$22.00
+1319.4%
Consensus
$22.00
+1319.4%
Bull
$22.00
+1319.4%
12-Month Target Range9 analysts
$22.00$22.00$22.00
Current $1.55Consensus
Current Price
$1.55
Upside to Consensus
$20.45

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+4670.01%
EPS
FY2028
Rev+294.03%
EPS
FY2029
Rev+285.29%
EPS

Earnings Surprises

Recent Analyst Actions

Aug 22, 2024Scotiabank
Scotiabank starts INmune with Outperform on Alzheimer's potential
Target:$22.00
+221.2%from $6.85